AHA Scientific Sessions 2025 Abstract
Overcoming Barriers For Research Participation In Minority Patients In Lp(a)FRONTIERS EXPANSION: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate Efficacy And Safety Of Pelacarsen In U.S. Black And Hispanic Patients with Elevated Lp(a) And Established ASCVD
By Keith C. Ferdinand, Fátima Rodríguez, Alok Ravindra Amraotkar, Show 5 more authorsMichael Shapiro
Trial in peopleInterventions
The paper
Tulane University; Wake Forest University Health Sciences
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4365650
